This content is from: Patents

Providing active pharmaceutical ingredient to ANDA defendant not induced infringement

The Federal Circuit has reversed a grant of summary judgment for induced infringement against a defendant who provided the active pharmaceutical ingredient to an ANDA defendant seeking to bring a generic onto the market

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial